US investment-grade bond spreads — the premium highly rated companies pay to borrow relative to the government — were at 0.8 ...

Gilead Sciences has underperformed the broader market ... The company’s earnings surprise history is mixed. It beat the consensus estimate in three of the past four quarters while missing ...

Gilead Sciences, Inc. today announced the presentation of new research data from its innovative HIV treatment portfolio and pipeline, including a broad range of data on investigational and marketed ...

Headquartered in Foster City, California, Gilead Sciences, Inc. (GILD) is a prominent biopharmaceutical company with a market ...

HAVERTYS today announced that Clarence H. Smith, CEO and chairman of the board, has chosen to retire from his position as CEO ...

Susie was born Susan Summerall, as one of three children of Pat Summerall and his wife Kathy Summerall. Pat played football ...

Anitocabtagene autoleucel may be a promising CAR-T cell therapy option for patients with relapsed/refractory myeloma.

Trump’s newly named WH chief of staff Susie Wiles retained her position as co-chair of the lobbying firm Mercury Public ...

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses.

A total of US$241.7bn in Yankee bank debt has been issued in 2024, which is already one of the strongest years for the market in recent history, BMO said ... Biopharmaceutical company Gilead Sciences ...

As a former trial attorney with more than a decade of litigation experience, Jamie L. Pfeiffer writes trustworthy, engaging ...